Secure Your Sensitive Drug Substances With Advanced Plate Freezing Performances

Protecting sensitive biological substances during freeze and thaw cycles is a critical challenge in biopharmaceutical development and manufacturing. These processes can compromise the integrity of delicate molecules, which leads to product degradation, reduced efficacy, and significant financial loss. To mitigate these risks, it is essential to employ advanced technologies that not only ensure precise temperature control but also offer user-friendly systems for safe storage and transport. In this webinar, delve into the potentially damaging effects of freezing and thawing on biological products and explore how Sartorius’ cutting-edge plate freezing platform—designed with compatible single-use containers—provides a robust solution for preserving the stability of sensitive molecules. This innovative approach combines high-performance engineering with operational simplicity, helping researchers and manufacturers maintain product quality throughout the cold chain.

Learn how you can enhance your freeze/thaw processes and safeguard your valuable biological assets.